You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Application of Thorne Research B-Complex No. 6 vitamin complex to reduce homocysteine levels in military personnel after injuries during rehabilitation

ISSN 2223-6775 Ukrainian Journal of Occupational Health, Vol. 19, 2023, Supplement

https://doi.org/10.33573/ujoh2023.Suppl.413

Application of Thorne Research B-Complex No. 6 vitamin complex to reduce homocysteine levels in military personnel after injuries during rehabilitation

Leonov Yu. I., Vergolyas M. R., Nechyporenko S. G., Baidalina V. Yu., Kryukova L. B.

State Institution «Kundiiev Institute of Occupational Health of the National Academy of Medical Sciences of Ukraine», Kyiv, Ukraine

Introduction. Folic acid intake can reduce homocysteine levels by a quarter, which leads to a decrease in the risk of cardiovascular disease. There are several different mechanisms of homocysteine pathogenesis and vascular disease.

The aim of the research – to investigate the effect of Thorne Research B-Complex No. 6 vitamin complex on homocysteine and folic acid levels in military personnel.

Materials and methods of the research. We administered the supplements to 25 patients, with the other 25 being the control group. Laboratory tests were conducted prior to and 2 months after taking the drugs. Laboratory diagnostics were used to analyze the drug's effect on the levels of homocysteine and folic acid.

Results. The use of Thorne Research B-Complex No. 6 resulted in a significant decrease in homocysteine levels (p < 0.01; p < 0.05).

Conclusion. Thorne Research B-Complex No. 6 effectively reduces homocysteine levels and significantly increases folic acid levels.

Key words: supplements, homocysteine, folic acid, B vitamins, haemoglobin, red blood cells

References

  1. Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14(1):1-10. DOI: https://doi.org/10.1186/1475-2891-14-6.
  2. Yang Q, He GW. Imbalance of homocysteine and H2S: significance, mechanisms, and therapeutic promise in vascular injury. Oxid Med Cell Longev. 2019. DOI: https://doi.org/10.1155/2019/7629673.
  3. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324(17):1149-55. DOI: https://doi.org/10.1056/NEJM199104253241701.
  4. Clarke R, Brattström L, Landgren F, et al. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ. 1998;316(7135):894-8. DOI: https://doi.org/10.1136/bmj.316.7135.894.
  5. Pushpakumar S, Kundu S, Sen U. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide. Ingenta Connect. 2014;21(32):3662-72. DOI: https://doi.org/10.2174/0929867321666140706142335.